Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Career Award (K) Policy Update: Concurrent Support from a Mentored K Award and a Research Grant
Office of the Director, NIH - Change to Activity Codes for PA-18-713: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)
Office of the Director, NIH - Notice of Correction to PAR-18-598 "High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)"
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Notice of Correction to PAR-18-599 "Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)"
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Notice of Correction to PAR-18-600 "Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)"
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - NCI Announcement of Interest in Supporting Immuno-Oncology Research and Career Development through NIH Parent PA-18-591, "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
National Cancer Institute - NCI Request for Information (RFI): Input on Development of the NCI Imaging Data Commons
National Cancer Institute - Notice of NCI's participation on PAR-18-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
National Cancer Institute
National Institute on Drug Abuse - Notice of Intent to Publish a Funding Opportunity Announcement for the Reissue of PA-18-568 International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)
National Institute on Drug Abuse - NIDCR Policy on Applications for Investigator-Initiated Clinical Trials
National Institute of Dental and Craniofacial Research - Notice of Corrected Application Forms for PAR-18-547, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institute of Dental and Craniofacial Research - Request for Information (RFI): NHLBI R35 Programs
National Heart, Lung, and Blood Institute - Notice of NINDS Policy for Submission of Applications Containing Clinical Trials
National Institute of Neurological Disorders and Stroke
Requests for Applications
- Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional)
- Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional)
- Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)
- Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional)
National Cancer Institute
- Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
- Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Program Announcements
- Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).
- Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).
National Cancer Institute
National Institute on Aging
National Institute of Dental and Craniofacial Research
National Institute of Nursing Research
- Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)
- Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
National Human Genome Research Institute
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
National Institute of Mental Health
- Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
National Institutes of Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
- Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
- Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
- Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
National Institute on Drug Abuse
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu